Your browser doesn't support javascript.
loading
Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma.
Uemura, Motohide; Nakaigawa, Noboru; Sassa, Naoto; Tatsugami, Katsunori; Harada, Kenichi; Yamasaki, Toshinari; Matsubara, Nobuaki; Yoshimoto, Takuya; Nakagawa, Yuki; Fukuyama, Tamaki; Oya, Mototsugu; Shinohara, Nobuo; Uemura, Hirotsugu; Tsuzuki, Toyonori.
Afiliação
  • Uemura M; Department of Urology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Nakaigawa N; Department of Urology, Yokohama City University Graduate School of Medicine, 22-2 Seto, Kanazawa Ward, Yokohama, Kanagawa, 236-0027, Japan.
  • Sassa N; Department of Urology, Nagoya University Graduate School of Medicine, Furocho, Chikusa Ward, Nagoya, Aichi, 464-8601, Japan.
  • Tatsugami K; Department of Urology, Aichi Medical University Hospital, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.
  • Harada K; Department of Urology, Kyushu University Graduate School of Medical Sciences, 3-1-1, Maidashi, Higashi-ku, Fukuoka City, 812-8582, Japan.
  • Yamasaki T; Department of Urology, Kitakyushu Municipal Medical Center, 2-1-1 Bashaku, Kokurakita Ward, Kitakyushu, Fukuoka, 802-0077, Japan.
  • Matsubara N; Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
  • Yoshimoto T; Department of Urology, Kyoto University Graduate School of Medicine, Yoshidakonoecho, Sakyo Ward, Kyoto, 606-8501, Japan.
  • Nakagawa Y; Department of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Fukuyama T; Biometrics Department, Chugai Pharmaceutical Co., Ltd., Nihonbashi Muromachi 2-1-1, Chuo City, Tokyo, 103-8324, Japan.
  • Oya M; Biometrics Department, Chugai Pharmaceutical Co., Ltd., Nihonbashi Muromachi 2-1-1, Chuo City, Tokyo, 103-8324, Japan.
  • Shinohara N; Medical Affairs Division, Chugai Pharmaceutical Co., Ltd., Nihonbashi Muromachi 2-1-1, Chuo City, Tokyo, 103-8324, Japan.
  • Uemura H; Department of Urology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku City, Tokyo, 160-8582, Japan.
  • Tsuzuki T; Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Kita 15, Nishi 7, Kita-ku, Sapporo, 060-8638, Japan.
Int J Clin Oncol ; 26(11): 2073-2084, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34291367
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Int J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Int J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão